Journal of Alzheimer's Disease

Last updated

Alzheimer Award

Each year, the Associate Editors of the journal select the best article from the previous year's volume. The awardee is presented the Alzheimer Medal, a 3" bronze medal with the likeness of Alois Alzheimer. This yearly award is sponsored by IOS Press and the winner of the Alzheimer Award receives a US$7,500 cash prize.

Related Research Articles

The Review of Financial Studies is a peer-reviewed academic journal covering the field of finance. It is published by Oxford University Press on behalf of the Society for Financial Studies. It was established following discussions at the 1986 Western Finance Association meetings, and the first issue was published in 1988. The current editor-in-chief is Itay Goldstein. It is considered to be one of the premier finance journals. According to the Journal Citation Reports, the journal has a 2020 impact factor of 5.814, ranking it 5/110 in the category "BUSINESS, FINANCE".

<i>Journal of Peptide Science</i> Academic journal

The Journal of Peptide Science is a monthly peer-reviewed scientific journal, published since 1995 by John Wiley & Sons on behalf of the European Peptide Society. The current editor-in-chief is Paolo Rovero.

<i>Human Molecular Genetics</i> Academic journal

Human Molecular Genetics is a semimonthly peer reviewed scientific journal published by the Oxford University Press. It covers all topics related to human molecular genetics. In addition, two "special review" issues are published each year. The editor-in-chief is CHaris Eng. The journal was established in 1992.

Clinical Infectious Diseases is a peer-reviewed medical journal published by Oxford University Press covering research on the pathogenesis, clinical investigation, medical microbiology, diagnosis, immune mechanisms, and treatment of diseases caused by infectious agents. It includes articles on antimicrobial resistance, bioterrorism, emerging infections, food safety, hospital epidemiology, and HIV/AIDS. It also features highly focused brief reports, review articles, editorials, commentaries, and supplements. The journal is published on behalf of the Infectious Diseases Society of America. The editor-in-chief is infectious disease physician Paul Sax.

Mark Anthony Smith was a professor of pathology at Case Western Reserve University in Cleveland, Ohio, where he also served as the Director of Basic Science Research at the University Memory and Aging Center. At the time of his death, he had been serving as Executive Director of the American Aging Association.

Entropy is a monthly open access scientific journal covering research on all aspects of entropy and information theory. It was established in 1999 and is published by MDPI. The journal occasionally publishes special issues compiled by guest editors. The editor-in-chief is Kevin H. Knuth.

<i>Annual Review of Phytopathology</i> Academic journal

The Annual Review of Phytopathology is a peer-reviewed academic journal that publishes review articles about phytopathology, the study of diseases that affect plants. It was first published in 1963 as the result of a collaboration between the American Phytopathological Society and the nonprofit publisher Annual Reviews. As of 2022, Journal Citation Reports lists the journal's 2021 impact factor as 10.850, ranking it seventh of 238 journal titles in the category "Plant Sciences". Its current editors are Jan E. Leach and Steven E. Lindow.

<i>Annual Review of Public Health</i> Academic journal

The Annual Review of Public Health is a peer-reviewed academic journal that publishes review articles about public health, including epidemiology, biostatistics, occupational safety and health, environmental health, and health policy. It has had three editors: Lester Breslow, Gilbert S. Omenn, and Jonathan E. Fielding.

IOS Press is a publishing house headquartered in Amsterdam, specialising in the publication of journals and books related to fields of scientific, technical, and medical research. Established in 1987, IOS Press publishes around 100 international journals and releases about 75 book titles annually, covering fields such as computer science, mathematics, the natural sciences, and topics within medicine.

<i>Journal of Integrative Neuroscience</i> Academic journal

The Journal of Integrative Neuroscience is a peer-reviewed scientific journal of neuroscience. It was published by World Scientific from 2002 to 2016, then IOS Press in 2017, and is now published by IMR Press since 2018. The editor-in-chief is Gernot Riedel.

Stephen Garrard Post has served on the Board of the John Templeton Foundation (2008-2014), which focuses on virtue and public life. He is a researcher, opinion leader, medical school professor, and best-selling author who has taught at the University of Chicago Medical School, Fordham University-Marymount, Case Western Reserve University School of Medicine (1988-2008) and Stony Brook University School of Medicine (2008-). He is widely known for his research on the ways in which giving can enhance the health and happiness of the giver, how empathy and compassionate care contribute to patient outcomes, ethical issues in caring for people with dementia, medical professionalism and the virtues, and positive psychology in relation to health and well-being. Post is an elected member of the College of Physicians of Philadelphia, the New York Academy of Medicine, and the Royal Society of Medicine, London. He was selected nationally as the Public Member of the United States Medical Licensing Examination (USMLE) Composite Committee (2000-2005), and was reappointed for outstanding contributions.

Lindsay H. Burns is an American neuroscientist and rower who won a silver medal at the 1996 Summer Olympics. She is a senior vice president of the pharmaceutical company Cassava Sciences and married to its CEO Remi Barbier.

Current Medicinal Chemistry is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Atta-ur-Rahman, FRS. The journal covers developments in medicinal chemistry and rational drug design and publishes original research reports and review papers.

<i>American Journal of Alzheimers Disease & Other Dementias</i> Academic journal

The American Journal of Alzheimer's Disease & Other Dementias is a peer-reviewed academic journal that publishes papers in the field of neurology. The journal's editor is Carol F. Lippa, MD. It has been in publication since 1986 and is currently published by SAGE Publications.

<span class="mw-page-title-main">Suh Yoo-hun</span>

Suh Yoo-hun is a South Korean neuroscientist. His researches focus on neurodegeneration, especially on the discovery of genes and therapies for Alzheimer's disease and Parkinson's disease.

Alzheimer's Research & Therapy is a monthly peer-reviewed medical journal covering research on Alzheimer's disease. It was established in 2009 and is published by BioMed Central. The editors-in-chief are Douglas R. Galasko, Todd E. Golde, and Philip Scheltens.

<i>NeuroRehabilitation</i> Academic journal

NeuroRehabilitation is a peer-reviewed medical journal covering all aspects of neurological rehabilitation. It was established in 1991 and is published by IOS Press. The editors-in-chief are Nathan D. Zasler and Jeffrey S. Kreutzer. The journal also occasionally publishes thematically organized issues that focus on specific clinical disorders, types of therapy, and age groups.

<i>Parasitology</i> (journal) Academic journal

Parasitology is a peer-reviewed scientific journal covering the area of parasitology, including the biochemistry, molecular biology, genetics, ecology and epidemiology of eukaryotic parasites, and the relationship between the host and the parasite. It was established in 1908 and is published fourteen times a year by Cambridge University Press. The editor-in-chief is John Russell Stothard.

<i>Journal of Huntingtons Disease</i> Academic journal

The Journal of Huntington's Disease is a quarterly peer-reviewed scientific journal in neuroscience that covers all aspects of Huntington's disease and related disorders. It was established in 2012 and is published by IOS Press. The editors-in-chief are Blair Leavitt and Leslie Thompson.

<span class="mw-page-title-main">Simufilam</span> Experimental drug for Alzheimers disease

Simufilam is an Investigational New Drug for the treatment of Alzheimer's disease in phase III clinical trials expected to finish in 2023 or 2024. It is being developed by the American pharmaceutical firm Cassava Sciences.

References

  1. "Journal of Alzheimer's Disease". 2020 Journal Citation Reports. Web of Science (Science ed.). Clarivate Analytics. 2020.